Bioactive Compound Analysis and Cytotoxic Potential of Belamcanda chinensis Leaf Extract
Abstract
ABSTRACT:Background: Belamcanda chinensis, commonly known as the leopardlily, is a medicinalplant traditionally used for its therapeutic properties. The purpose of this study was to examinethe phytochemical makeup and cytotoxic potential of an extract from Belamcanda chinensisleaves. Methods: To find the presence of bioactive substances, phytochemical screening wasdone. To characterise the ethyl acetate fraction, high-resolution liquid chromatography-massspectrometry (HR-LCMS) was employed. The MTT assay was used to evaluate in vitrocytotoxicity at doses of 125, 250, 500, and 1000 μg/ml using the MCF-7 breast cancer cell line.The IC50 values and % cytotoxicity were computed. Results: A total ash content of 4.63±0.53%w/w was found by the physico-chemical analysis, with a high water soluble ash value of24.21±0.783% w/w, indicating considerable mineral contents. The presence of alkaloids,flavonoids, tannins, saponins, and glycosides was verified by phytochemical screening.Compounds with significant biological activity were found by HR-LCMS analysis, includingCerberoside and Sanguisorbin E. The MTT assay showed that both ethanolic (ET-01) and ethylacetate (EA-02) extracts exhibited significant cytotoxicity against MCF-7cells. ET-01 had anIC50 value of 336.00μg/ml with 73.43% cytotoxicity at 1000μg/ml, while EA-02 had an IC50value of 348.83μg/ml with 78.33% cytotoxicity at the same concentration. Conclusion: Thestudy demonstrates that Belamcanda chinensis leaves extract contains a rich array of bioactivecompounds with significant cytotoxic effects against breast cancer cells. These findings supportits potential use in developing new anticancer agents and warrant further investigation into itstherapeutic applications.
Fields of Study & Subjects
Phytochemical Studies and Bioactivities
Medicinal Plant Research
Phytochemistry Medicinal Plant Applications
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 12 January 2026
- Language
- EN